Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 16, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K

Sclerostin expression in skeletal sarcomas.

Jia Shen1, Carolyn A Meyers2, Swati Shrestha2

  • 1Division of Growth and Development and Section of Orthodontics, School of Dentistry, University of California, Los Angeles, CA 90095; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.

Human Pathology
|August 8, 2016
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Frequency Spinal Cord Stimulation Modifies Tibial Nerve-Stimulation-Evoked Cortical Theta-Gamma Coupling in Sheep Cortex.

The European journal of neuroscience·2026
Same author

Scleral thickness in young children.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2026
Same author

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Dietary omega-6 lipids promote post-injury aberrant bone formation in obesity.

The Journal of clinical investigation·2026
Same author

Sensory nerves protect against preclinical tendinopathic changes through FGF1 signaling.

Science translational medicine·2026
Same author

Sex-dependent mechanisms of temporomandibular joint osteoarthritis.

JBMR plus·2026

Sclerostin (SOST) is frequently found in bone and cartilage tumors, acting as a feedback inhibitor of osteogenic differentiation. Its expression in osteosarcoma correlates with bone formation, not Wnt signaling activity.

Area of Science:

  • Oncology
  • Endocrinology
  • Biochemistry

Background:

  • Sclerostin (SOST) is a key antagonist of Wnt signaling, regulating bone mass.
  • The role and expression of SOST in skeletal tumors are not well understood.
  • Understanding SOST in tumors is crucial given its therapeutic potential for osteoporosis.

Purpose of the Study:

  • To investigate the expression pattern of SOST in benign and malignant skeletal tumors.
  • To compare SOST expression with Wnt signaling activity and osteogenic differentiation markers in osteosarcoma cell lines.

Main Methods:

  • Immunohistochemical staining of SOST in 68 primary skeletal tumors.
  • Quantitative analysis of SOST expression in 7 human osteosarcoma cell lines.
  • Correlation analysis with Wnt signaling markers and alkaline phosphatase.
Keywords:
ChondrosarcomaEnchondromaOsteosarcomaSOSTSarcomaWnt signaling

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

7.0K

Related Experiment Videos

Last Updated: Mar 16, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

7.0K

Main Results:

  • SOST was detected in 90.2% of bone-forming and 100% of cartilage-forming tumors.
  • SOST expression in osteosarcoma correlated with neoplastic bone presence and degree.
  • SOST expression in cell lines varied widely and correlated with osteogenic differentiation, not Wnt signaling.

Conclusions:

  • SOST is commonly expressed in skeletal bone- and cartilage-forming tumors.
  • SOST functions as a feedback inhibitor of osteogenic differentiation in these tumors.
  • The biological consequences of SOST in skeletal tumors warrant further investigation for potential therapeutic implications.